EFFECTIVE ANTIBODY THERAPIES
Our products are the result of the extensive experience, expertise, and commitment of many employees and partners throughout the world.
TARGETED CANCER AND REJECTION TREATMENTS
With our effective antibody therapies, we specifically influence the body’s immune system to fight malignant cells and to improve transplant tolerance.
INNOVATION AND OPTIMIZATION OF EXISTING PRODUCTS
Solving unmet medical needs through continued development of new and existing antibody technologies.
CREATING THE FUTURE TOGETHER
Find out more about our focus areas and offers for our partners. We look forward to shaping the future with you.
Welcome to Neovii
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology.
Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in over 50 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.
There are differences in approved indications between countries so please refer to local country information for details.